Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade D 228.36 1.08% 2.43
BDX closed up 1.08 percent on Friday, May 17, 2019, on 1.73 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical BDX trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
Outside Day Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 1.08%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.08%
Slingshot Bearish Bearish Swing Setup 1.08%
Cup with Handle Other 1.08%

Older signals for BDX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies New Jersey Cancers Medical Technology Catheters Medical Devices Medical Tests Drug Delivery Healthcare Associated Infections Treatment Of Diabetes Healthcare Institutions Drug Delivery Systems Laboratory Products Syringe Becton Clinical Tools
Is BDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 265.87
52 Week Low 208.62
Average Volume 1,426,878
200-Day Moving Average 242.9124
50-Day Moving Average 240.7544
20-Day Moving Average 231.67
10-Day Moving Average 228.483
Average True Range 5.4349
ADX 31.81
+DI 11.3145
-DI 23.6519
Chandelier Exit (Long, 3 ATRs ) 224.6453
Chandelier Exit (Short, 3 ATRs ) 237.7747
Upper Bollinger Band 242.9198
Lower Bollinger Band 220.4202
Percent B (%b) 0.35
BandWidth 9.711918
MACD Line -4.3078
MACD Signal Line -3.9652
MACD Histogram -0.3426
Fundamentals Value
Market Cap 51.97 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 66.19
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.28%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 237.20
Resistance 3 (R3) 236.69 233.24 235.72
Resistance 2 (R2) 233.24 230.99 233.49 235.23
Resistance 1 (R1) 230.80 229.60 232.02 231.31 234.74
Pivot Point 227.35 227.35 227.96 227.60 227.35
Support 1 (S1) 224.91 225.10 226.13 225.42 221.98
Support 2 (S2) 221.46 223.71 221.71 221.49
Support 3 (S3) 219.02 221.46 221.00
Support 4 (S4) 219.53